The European Medicines Agency announced a study last fall that found the UK’s most widely prescribed antidepressant, Citalopram, causes 3x more cardiac abnormalities, including fatal ones, than other antidepressants. The UK’s Medicines and Healthcare products Regulatory Agency is receiving criticism for not making the recommendation public. The recommendation is for a lower dosage, though there is no research on the safety of the lower dose.
Antidepressant citalopram heart safety warning
Mad in America hosts blogs by a diverse group of writers. These posts are designed to serve as a public forum for a discussion—broadly speaking—of psychiatry and its treatments. The opinions expressed are the writers’ own.
Mad in America has made some changes to the commenting process. You no longer need to login or create an account on our site to comment. The only information needed is your name, email and comment text. Comments made with an account prior to this change will remain visible on the site.